Clinical trial

Evaluating the Effect of Ursodeoxycholic Acid in Patients With Rheumatoid Arthritis

NCT05973370

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-05-01

PhasePHASE2

Study timeline

Study start (actual)2023-05-01Date precision: day

Registry last updated2024-06-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

PlaceboDRUG

Ursodeoxycholic acid (UDCA) 500 mgDRUG

Sponsors & collaborators

Tanta Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05973370 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.